Prednisolone
Brand names: Deltacortril, Prednesol
Prednisolone is a synthetic glucocorticoid corticosteroid used widely for its anti-inflammatory and immunosuppressive effects across endocrine, respiratory, rheumatological and other inflammatory conditions, and as physiological replacement in adrenal insufficiency.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It binds intracellular glucocorticoid receptors to modulate gene transcription, suppressing inflammatory mediators and immune cell activity while exerting metabolic and mineralocorticoid effects.
Prescribing in practice
- Never stop prolonged or high-dose therapy abruptly; the dose must be tapered to avoid acute adrenal crisis, and patients require a steroid emergency card and sick-day rules.
- Chronic use predisposes to osteoporosis, hyperglycaemia, hypertension, weight gain, infection and adrenal suppression; consider bone and gastric protection where appropriate.
- Take with food, ideally in the morning to mimic the circadian cortisol rhythm and reduce sleep disturbance.
Monitoring
Monitor weight, blood pressure, blood glucose, signs of infection and, with long-term use, bone density and growth in children.
Counselling the patient
- Do not suddenly stop taking your steroid tablets, even if you feel well.
- Carry your steroid emergency card at all times and increase the dose during illness as advised.
- Tell your team if you develop signs of infection or have chickenpox or measles contact, as steroids blunt your immune response.
Evidence & guidelines
MHRA advises all patients on systemic corticosteroids carry a steroid emergency card, reflecting the established risk of adrenal crisis on abrupt withdrawal or intercurrent illness.
Reference: NICE NG137; UK guidelines; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Steroid Dose Equivalence · Medications
- Maddrey Discriminant Function (Alcoholic Hepatitis) · Alcoholic Liver Disease
- Lille Model (Steroid Response in Alcoholic Hepatitis) · Alcoholic Liver Disease
- Maddrey's Discriminant Function for Alcoholic Hepatitis · Hepatology
- Lille Model for Alcoholic Hepatitis · Hepatology
- Mayo Score for Ulcerative Colitis Activity · Inflammatory Bowel Disease
- Diabetic Ketoacidosis (DKA) · JBDS 2013 / Joint British Diabetes Societies; NICE NG17
- Adult Hypoglycaemia (Treated Diabetes) · JBDS-IP (2023): Hospital Management of Hypoglycaemia
- Adrenal Crisis · Society for Endocrinology Emergency Guidance (2024)
- Type 2 Diabetes Management · NICE NG28 2022
- Hyperthyroidism Management · BTA / ETA 2018
- Adrenal Insufficiency · Society of Endocrinology / ESE 2016
Featured in these MRCEM clinical pathways
Prednisolone is a core drug in the following exam-focused workups on our sister siteReviseMRCEM.
MRCEM Primary / Intermediate / OSCE candidates: each pathway includes exam-style questions, RCEM/NICE citations, and FAQ summaries.